Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tacrolimus vs Systemic MMF for Repeat Keratoplasty
NCT04147390Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Tacrolimus Ointment 0.1% Iwaki in corneal graft rejection (CGR), sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
corneal graft rejection (CGR)
Beyond the preview
Go deeper on NCT04147390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147390.